Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
Clinical trial NCT07237256 · RECRUITING
Trial details
- NCT number
- NCT07237256
- Sponsor
- UNICANCER
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-18
- Primary completion
- 2033-11-30
- Enrollment
- 3902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.